Shaji Kumar, MD | Authors

Articles

Venetoclax for Multiple Myeloma: The Phase 3 BELLINI Trial

April 18, 2022

Sponsored in Part by AbbVie/Content Independently Developed by Targeted Oncology. Dr. Shaji Kumar reviews data from his BELLINI clinical trial studying venetoclax paired with bortezomib and dexamethasone for multiple myeloma treatment.

Venetoclax plus Dexamethasone for Multiple Myeloma Treatment

April 16, 2022

Sponsored in Part by AbbVie/Content Independently Developed by Targeted Oncology. Dr. Jonathan Kaufman explains clinical trial data on the efficacy of dexamethasone with venetoclax for multiple myeloma treatment.